Activity of soil fluorescein diacetate (FDA) hydrolase under long-term fertilization by MA Xing-zhu

Subjects: Get full text

“Common questions and misconceptions about dietary supplements and the industry - What does science and the law really say?“ by Jose Antonio, Brandi Antonio, Alan Aragon, Erik Bustillo, Darren Candow, Rick Collins, Edwin Davila, Bob Durkin, Douglas Kalman, Chris Lockwood, Scotty Mills, Jeffrey R. Stout

Subjects: Get full text

Vaccine Dosing Considerations in Product Labels and ACIP Recommendations: A Review by Kunal Saxena, Kate Mevis, Sofia Toso, Elif Alyanak, Natasha Hansen, Aliana Potter, Molly Flannery, Mona Saraiya

Subjects: Get full text

Drug-induced cardiac arrest: a pharmacovigilance study from 2004–2024 based on FAERS database by Gaocan Ren, Gaocan Ren, Pingping Huang, Pingping Huang, Jinhui Zhang, Jin Liu, Zian Yan, Xiaochang Ma, Xiaochang Ma, Xiaochang Ma

Subjects: Get full text

PROBLEMS OF CONFORMITY OF THE RECORDS INTEGRITY WITH THE REQUIREMENTS OF GOOD MANUFACTURING PRACTICE. REPORT 1. ACTUALITY OF THE RECORDS INTEGRITY CONSERVATION by I. A. Osmolovskaya, O. V. Zarochinskaya, M. O. Emelianov, D. V. Somov

Subjects: Get full text

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization by Triana Amen, Daniel Kaganovich

Subjects: Get full text

Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors by Mohammed Hawash

Subjects: Get full text

2024 FDA TIDES (Peptides and Oligonucleotides) Harvest by Othman Al Musaimi, Danah AlShaer, Beatriz G. de la Torre, Fernando Albericio

Subjects: “…FDA approvals…”
Get full text

Implementation of hazard analysis and critical control points (HACCP) in Indian biopharmaceutical industries: A field study by Kritangni Dhiman, Navjeevan Dadwal

Subjects: Get full text

A Proposed New Path for Management of Health in Inherited Metabolic Disorders Using Engineered Probiotic Bacteria by Kurtz CB, Calvo MS

Subjects: Get full text

Postmarketing adverse events associated with onasemnogene abeparvovec: a real-world pharmacovigilance study by Tianyu Chen, Qiying Chen, Jingfang Ye, Yuzhu Wu, Ting Liu, Yuezhen Zhang

Subjects: Get full text

Overview of drugs approved by the FDA in 2022 by D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina

Subjects: “…fda…”
Get full text

A functional data analysis approach for modelling frequency‐modulated tonal sounds in animal communication by Maria Silvia Labriola, Petra Oswine Pammer, Giulia Pedrazzi, Giancarlo Giacomini, Giovanna Jona Lasinio, Daniela Silvia Pace

Subjects: Get full text

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease by Israa J. Hakeem, Hadil Alahdal, Hanadi M. Baeissa, Tahani Bakhsh, Misbahuddin Rafeeq, Alaa Hamed Habib, Mohammed Matoog Karami, Maryam A. AL-Ghamdi, Ghadeer Abdullah, Abeer Al Tuwaijri

Subjects: Get full text

A Search for FDA Approved Drugs with Multiple Antiemetic Targets: A Computational-Based Drug Repositioning Study by Abdulmajeed Yunusa*1, Albashir Tahir1,2

Subjects: “…antiemetics, drug repositioning, molecular docking, fda-approved drugs…”
Get full text

Food Traceability Rule Overview: A Guide for Florida Food Industry by Sharon Chuah, Razieh Farzad

Subjects: Get full text

Safety Concerns in Neurological Clinical Trials: A Challenge That the FDA Must Resolve by Sarfaraz K. Niazi

Subjects: Get full text

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone by Cameron Louttit

Subjects: Get full text

Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases by Gaocan Ren, Xiansu Chi, Pingping Huang, Jinhui Zhang, Yanqiu Ding, Lijun Guo, Qinghua Shang, Xiaochang Ma

Subjects: Get full text

Scientific Justification and Policy Recommendations to the US Food and Drug Administration for Waiving Comparative Efficacy Studies by Sarfaraz K. Niazi

Subjects: Get full text